Document:

Senior Executive Supplemental Retirement Plan, as amended and restated

 Exhibit 10.5 
 DOLBY LABORATORIES, INC. 
 SENIOR EXECUTIVE 
 SUPPLEMENTAL RETIREMENT PLAN 
 Effective Date: October 1, 1994 
 Amended and Restated Effective January 1, 2005 
 Terminated Effective August 2, 2005 
 Amended and Restated Effective January 1, 2008 

 TABLE OF CONTENTS 
  

					
	 Section 1.
	  	 Purpose of the Plan
	  	1
			
	 Section 2.
	  	 Definitions
	  	1
	 2.1
	  	 “Account”
	  	1
	 2.2
	  	 “Beneficiary”
	  	1
	 2.3
	  	 “Board”
	  	1
	 2.4
	  	 “Change of Control”
	  	1
	 2.5
	  	 “Code”
	  	2
	 2.6
	  	 “Committee”
	  	2
	 2.7
	  	 “Company”
	  	2
	 2.8
	  	 “Compensation”
	  	2
	 2.9
	  	 “Disability”
	  	2
	 2.10
	  	 “Effective Date”
	  	2
	 2.11
	  	 “Employer”
	  	2
	 2.12
	  	 “ERISA”
	  	3
	 2.13
	  	 “Insolvency”
	  	3
	 2.14
	  	 “Investment Fund”
	  	3
	 2.15
	  	 “Participant”
	  	3
	 2.16
	  	 “Payment Date”
	  	3
	 2.17
	  	 “Plan”
	  	3
	 2.18
	  	 “Plan Year”
	  	3
	 2.19
	  	 “Projected Average Monthly Compensation”
	  	3
	 2.20
	  	 “Senior Executive”
	  	4
	 2.21
	  	 “Separation from Service”
	  	4
	 2.22
	  	 “Termination Date”
	  	4
	 2.23
	  	 “Trust”
	  	4
	 2.24
	  	 “Trustee”
	  	4
	 2.25
	  	 “Valuation Date”
	  	4
	 2.26
	  	 “Year of Benefit Service”
	  	4
	 2.27
	  	 “Year of Service”
	  	4
			
	 Section 3.
	  	 Administration of the Plan
	  	5
	 3.1
	  	 Generally
	  	5
			
	 Section 4.
	  	 Eligibility
	  	5
	 4.1
	  	 Participation
	  	5
	 4.2
	  	 Cessation of Participation
	  	5
			
	 Section 5.
	  	 Contributions
	  	5
	 5.1
	  	 Target Benefit
	  	5
	 5.2
	  	 Crediting of Contributions
	  	7
	 5.3
	  	 Time for Making Contributions
	  	8
			
	 Section 6.
	  	 Investment of Accounts
	  	8
	 6.1
	  	 Investment Direction
	  	8

					
	 6.2
	  	 Allocation of Income
	  	8
			
	 Section 7.
	  	 Distribution
	  	9
	 7.1
	  	 Termination
	  	9
	 7.2
	  	 Death Benefit
	  	9
	 7.3
	  	 Methods of Distribution
	  	9
	 7.4
	  	 Installment Payments
	  	9
	 7.5
	  	 Default Method of Distribution
	  	10
	 7.6
	  	 Special Distribution Election
	  	10
	 7.7
	  	 Acceleration of Distributions
	  	10
			
	 Section 8.
	  	 Beneficiary
	  	10
	 8.1
	  	 Designation of Beneficiary
	  	10
	 8.2
	  	 Automatic Designation
	  	10
			
	 Section 9.
	  	 Participant’s Rights Held in “Rabbi” Trust
	  	11
			
	 Section 10.
	  	 Time of Allocation
	  	11
			
	 Section 11.
	  	 Vesting of Plan Benefits
	  	11
			
	 Section 12.
	  	 Miscellaneous Provisions
	  	11
	 12.1
	  	 Nonassignability
	  	11
	 12.2
	  	 No Enlargement of Employment Rights
	  	11
	 12.3
	  	 Applicable Law
	  	11
	 12.4
	  	 Gender and Number
	  	11
			
	 Section 13.
	  	 Amendments and Termination
	  	12
	 13.1
	  	 Generally
	  	12
	 13.2
	  	 Distribution upon Termination
	  	12
			
	 Section 14.
	  	 Expenses
	  	12
			
	 Section 15.
	  	 Claims Procedures
	  	12
	 15.1
	  	 Applications for Benefits and Inquiries
	  	12
	 15.2
	  	 Denial of Claims
	  	12
	 15.3
	  	 Request for a Review
	  	13
	 15.4
	  	 Decision on Review
	  	14
	 15.5
	  	 Rules and Procedures
	  	14
	 15.6
	  	 Exhaustion of Remedies
	  	15
			
	 Section 16.
	  	 Execution
	  	15

  

 ii 

 DOLBY LABORATORIES, INC. 
 SENIOR EXECUTIVE 
 SUPPLEMENTAL RETIREMENT PLAN 
 Section 1. Purpose of the Plan. 
 Dolby
Laboratories, Inc. (“Company”) wishes to provide to certain executives of Dolby a vehicle by which selected senior executives may fulfill their pension expectations. The purpose of this Plan is to provide a select group of management and
highly compensated employees (as defined in Section 201(2) of ERISA) employed by the Company in the United States with the opportunity to receive a retirement income benefit in addition to any benefits provided under other Company sponsored
plans. The Plan is intended to comply with Code Section 409A in order to avoid compensation deferred under the Plan from being included in the gross income of Participants under Code Section 409A. 
 Section 2. Definitions. 
 Except as otherwise
indicated, all definitions in this Plan shall have the meaning as indicated below: 
 2.1 “Account” means the account
maintained for a Participant to record his interest under the Plan. An Account may not be encumbered or assigned by a Participant or any Beneficiary. 
 2.2 “Beneficiary” means any person or entity determined as such under Section 8 who is entitled to receive payments under the Plan because of the death of a Participant. 
 2.3 “Board” means the Board of Directors of the Company. 
 2.4 “Change of Control” means the purchase or other acquisition by any person, entity or group of persons, within the meaning of section 13(d) or 14(d) of the Securities Exchange Act of 1934
(“Act”), or any comparable successor provisions, or beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Act) of 30 percent or more of either the outstanding shares of common stock or the combined voting power of
Company’s then outstanding voting securities entitled to vote generally, or the approval by the stockholders of 

  

 1 

 
Company of a reorganization, merger, or consolidation, in each case, with respect to which persons who were stockholders of Company immediately prior to such
reorganization, merger or consolidation do not immediately thereafter, own more than 50 percent of the combined voting power entitled to vote generally in the election of directors of the reorganized, merged or consolidated Company’s then
outstanding securities, or a liquidation or dissolution of Company or of the sale of all or substantially all of Company’s assets. 
 2.5 “Code” means the Internal Revenue Code of 1986, as amended. 
 2.6 “Committee” means the
administrative Committee of three (3) persons (or such other number as the Board may designate) who shall be appointed by, and who shall serve at the pleasure of, the Board as outlined in Section 3. 
 2.7 “Company” means Dolby Laboratories, Inc. 
 2.8 “Compensation” means with respect to any Participant the total base compensation paid to a Participant by the Company for a Plan Year. 
 2.9 “Disability” means a medically determinable physical or mental impairment which can be expected to result in death or can be
expected to last for a continuous period of not less than twelve months, as a result of which the Participant is receiving income replacement benefits for a period of not less than three months under an accident and health plan covering employees of
the Company and its wholly owned subsidiaries. 
 2.10 “Effective Date” means October 1, 1994. 
 2.11 “Employer” means the Company or the entity for whom services are performed and with respect to whom the legally binding right to
compensation arises, and all entities with whom the Company would be considered a single employer under Code Section 414(b); provided that in applying Code Section 1563(a)(1), (2), and (3) for purposes of determining a controlled
group of corporations under Section 414(b) of the Code, the language “at least 50 percent” is used instead of “at least 80 percent” each place it appears in Code Section 1563(a)(1), (2), and (3), and in applying
Treasury Regulation § 1.414(c)-2 for purposes of determining trades or businesses (whether or not incorporated) that are under common control for purposes of Code Section 414(c) “at least 50 percent” is used instead of “at
least 80 percent” each place it appears in Treasury Regulation § 1.414(c)-2; provided, however, “at least 20 percent” shall replace “at least 50 percent” in the preceding clause if there is a legitimate business
criteria for using such lower percentage. 
  

 2 

 2.12 “ERISA” means the Employee Retirement Income Security Act of 1974, as amended.

 2.13 “Insolvency” means either if (i) Company is unable to pay its debts as they become due, or (ii) Company is
subject to a pending proceeding as a debtor under the United States Bankruptcy Code. 
 2.14 “Investment Fund” means such
investment funds or vehicles as may be selected by the Committee for the investment of Account balances under the Plan. 
 2.15
“Participant” means any Senior Executive or former Senior Executive who is participating in the Plan. 
 2.16
“Payment Date” means as soon as administratively practicable, but not later than 90 days, after six months following a Participant’s Separation from Service, or the Participant’s Termination Date, as applicable.

 2.17 “Plan” means the Dolby Laboratories, Inc. Senior Executive Supplemental Retirement Plan as set forth in this
document. 
 2.18 “Plan Year” means the twelve month period beginning October 1 and ending September 30. The first
Plan Year is the year beginning October 1, 1994. 
 2.19 “Projected Average Monthly Compensation” means a
Participant’s monthly Compensation averaged over the thirty-six (36) consecutive months of service in the final three Plan Years preceding his attainment of age 65. For purposes of this Plan, Projected Average Monthly Compensation shall be
based on the Participant’s annualized rate of Compensation as of 
  

	 	(a)	June 1, 1995, increased by 5% per annum for each future Plan Year after September 30, 1995, for individuals who became Participants on the Plan’s Effective Date;
or 

  

	 	(b)	September 30 of the Plan Year in which the individual becomes a Participant, increased by 5% per annum for each future Plan Year after such September 30 for
individuals who become Participants after the Plan’s Effective Date. 

  

 3 

 2.20 “Senior Executive” means an employee of the Company that has been designated
eligible to participate in this Plan. 
 2.21 “Separation from Service” means a termination of employment with an Employer,
other than by reason of death. A Participant shall not be deemed to have Separated from Service if the Participant continues to provide services to an Employer at an annual rate that is fifty percent or more of the services rendered, on average,
during the immediately preceding three full years of employment with an Employer (or if employed by an Employer less than three years, such lesser period); provided, however, that a Separation from Service will be deemed to have occurred if a
Participant’s service with an Employer is reduced to an annual rate that is less than twenty percent of the services rendered, on average, during the immediately preceding three years of employment with an Employer (or if employed by an
Employer less than three years, such lesser period). 
 2.22 “Termination Date” means the date a Participant is no longer
treated as employed by an Employer on account of his death. 
 2.23 “Trust” means the nonqualified “Rabbi” trust
created by the Trustee and Company under the terms of the Plan. 
 2.24 “Trustee” means the person or persons named under
the Trust as trustees. 
 2.25 “Valuation Date” means the last day of the Plan Year or the last day of each calendar quarter
or month, as the Plan Committee may determine. 
 2.26 “Year of Benefit Service” means a Plan Year in which a Participant is
credited with 1,000 hours of service as an employee with the Company. Participant will also be credited with 1/12 of a Year of Benefit Service to the nearest full calendar month of employment with the Company during the Plan Year in which such
Participant dies or suffers a Disability provided that such Plan Year precedes the Plan Year containing the Participant’s 65th birthday. 
 2.27 “Year of Service” means a Plan Year in which an employee is credited with at least 1,000 hours of service by the Company. 
  

 4 

 Section 3. Administration of the Plan. 
 3.1 Generally. The Plan shall be administered by the Plan Committee comprised of three (3) persons (or such other number as designated by the
board of directors of the Company) who shall be appointed by the Board of Directors of the Company. All decisions required to be made involving the interpretation, application and administration of the Plan shall be resolved by majority vote either
at a meeting or in writing without a meeting. 
 3.2 Recordkeeping Responsibility. The Plan Committee shall have the primary
responsibility for record keeping with respect to Plan benefits and for filing such written notices and/or reports as may be required by the Department of Labor. 
 Section 4. Eligibility. 
 4.1 Participation. Participation in this Plan shall be limited to Senior Executives
or former Senior Executives who are designated by the Board as executives eligible to participate in the Plan. Notwithstanding any other provision of the Plan to the contrary, no new Participants shall be designated by the Board after
October 1, 2004. 
 4.2 Cessation of Participation. A Participant’s status as such will cease as of his Separation from
Service, Termination Date, or the date he otherwise ceases to be a Participant as determined by the Board; provided, however, the term “Participant” will include any former Participant who has not received all payments to which he is
entitled under the Plan under Section 7. 
 Section 5. Contributions. 
 5.1 Target Benefit. The Company will contribute amounts on behalf of each Participant which are projected to fund an assumed monthly target benefit
payable to each Participant beginning at age 65, payable in the form of a joint and 50% survivor annuity, equal to the product of (i) and (ii): 
  

	 	(i)	2.00% of the Participant’s Projected Average Monthly Compensation, multiplied by 

  

 5 

	 	(ii)	a Participant’s total expected Years of Benefit Service up to 30 years, computed to the nearest full calendar month of completed service. 

 For this purpose, expected Years of Benefit Service includes all Years of Benefit Service rendered prior to October 1, 1994, and all Years of Benefit Service
expected to be rendered after September 30, 1994 on the assumption the Participant renders at least 1,000 hours of service as a Participant in each year. 
 The contributions will be determined by using an 8% per annum interest rate, post-retirement mortality based on the 1983 Group Annuity Mortality Table, and an assumption that each Participant is male with a spouse three years younger.
Notwithstanding anything to the contrary, a Participant’s target benefit is not guaranteed, and the Participant’s Account balance will vary according to the investment performance of the Trust. A Participant’s Account will be
comprised of two components: 
  

	 	(1)	Past Service Component: 

  

	 	(a)	With respect to individuals who became Plan Participants on the Effective Date, the actuarial present value of the target benefit based on Years of Benefit Service and monthly rate
of Compensation as of June 1, 1995. This past service component shall be contributed to the Trust by the Company on or after October 1, 1994. To the extent contributions are made after October 1, 1994, they shall be adjusted
(increased) with interest at 8% per annum. 

  

	 	(b)	With respect to individuals who become Plan Participants after the Effective Date, the actuarial present value of the target benefit based on Years of Benefit Service and monthly
rate of Compensation as of September 30 of the Plan Year in which the individual becomes a Participant. This past service component shall be contributed to the Trust by the Company on or after such September 30. To the extent contributions
are made after such September 30, they shall be adjusted (increased) with interest at 8% per annum. 

  

 6 

	 	(2)	Future Service Component: 

  

	 	(a)	With respect to individuals who became Plan Participants on the Effective Date, a level annual Company contribution amount to be contributed to the Trust at the end of each Plan
Year ending prior to the Participant’s attainment of age 65. The present value of the annual future service contributions for each Participant shall be equal to the difference between the present value of the Participant’s projected target
benefit at age 65, and the past service component, both determined as of October 1, 1994. 

  

	 	(b)	With respect to individuals who become Plan Participants after the Effective Date, a level annual Company contribution amount to be contributed to the Trust at the end of each Plan
Year (commencing with the first Plan Year after the initial year of Plan participation) and ending with the Plan Year prior to the Participant’s attainment of age 65. The present value of the annual future service contributions for each
Participant shall be equal to the difference between the present value of the Participant’s projected target benefit at age 65, and the past service component, both determined as of September 30 of the Plan Year in which the individual
becomes a Participant. 

 5.2 Crediting of Contributions. The Plan Committee shall establish and maintain an Account for
each Participant. As of the last day of each Plan Year, for each Participant who is employed by the Company on such date, the Trustee shall allocate the contribution determined under Section 5.1. No contribution shall be allocated to an Account
of a Participant who is not employed on the last day of the Plan Year, except that a Participant is entitled to receive a pro-rata contribution for such Plan Year where a partial Year of Benefit Service is credited under Section 2.26.
Notwithstanding any other provision of the Plan to the contrary, no contribution shall be made for any Plan Year beginning on or after October 1, 2004. 
  

 7 

 5.3 Time for Making Contributions. The Company will make annual contributions to the Trust for
each Plan Year, with such payments to be allocated among Participants’ Accounts by the Plan Committee as of the last day of the Plan Year. The Company’s annual contribution to the Trust may be made in one or more installments, payable as
of the end of the Plan Year, and adjusted for interest attributable to the timing of the installment in relation to the end of the Plan Year. 
 Section
6. Investment of Accounts. 
 6.1 Investment Direction. 
  

	 	(a)	Unless the Board elects otherwise, the Trustee may invest the Trust solely in Investment Funds selected by the Participants. The Plan Committee or the Board shall have the right to
determine, from time to time, the options that shall be offered with respect to the investment of such Accounts, including percentage increments in which such Accounts may be divided among Investment Funds, the maximum number of Investment Funds in
which they may invest their Accounts at one time, the times and effective dates of elections to change investment of such Accounts, the Investment Fund(s) in which such Accounts will be held in the event an investment election is not made, the
administrative costs to be charged to individuals for processing of investment election changes and any other elements affecting the investment of Accounts. 

  

	 	(b)	If the Participant has not directed the Trustee or Plan Committee to invest his Accounts in selected Investment Funds, when he or she first becomes a Plan Participant, then the
Trustee may invest such Participant’s Account in a money market type Investment Fund until such direction from the Participant is obtained. 

 6.2 Allocation of Income. If a Participant so designates the investment of his Accounts in Investment Funds to the Trustee or the Plan Committee, his Account will be credited with investment earnings or losses
based upon the performance of each Participant’s investment elections, until the Account has been fully distributed to a Participant or to the Beneficiary or Beneficiaries designated by the Participant in writing delivered to the Company.
Pending complete distribution to a Participant, assets in Accounts will be Company assets and income derived thereon will be income to the Company. 
  

 8 

 Section 7. Distribution. 
 7.1 Termination. Upon termination of the services or employment of a Participant with an Employer for any reason other than death, the Participant will be entitled to the value of his Account balance determined
as of the Valuation Date immediately preceding his Payment Date. Earnings or losses of the Investment Fund(s) will continue to be allocated to a Participant’s Account as long as he has an Account balance as of any Valuation Date following his
Termination Date or Separation from Service. Distributions shall be made, or begin to be made, on the Payment Date. 
 7.2 Death
Benefit. Upon termination of a Participant’s service or employment with an Employer by reason of his death, the Participant’s designated Beneficiary will be entitled to receive all amounts credited to the Account of the Participant as
of the date of his death that have not yet been distributed. Said amounts shall be payable in a single lump sum on the Payment Date. Upon the death of a former Participant prior to complete distribution to him of the entire balance of his Account
(and after his Termination Date or Separation from Service), the balance of his Account on the date of his death shall be paid to the Participant’s designated Beneficiary in a lump sum on the Payment Date. 
 7.3 Methods of Distribution. The Company shall direct distribution of the amounts credited to a Participant’s Account, including investment
income (and losses) credited thereon pursuant to Section 6, to a Participant or his Beneficiary pursuant to the preceding Sections 7.1 or 7.2, in a lump sum. Effective January 1, 2005, a Participant may elect pursuant to Section 7.6
to receive distribution of amounts credited to his Account in a lump sum or in up to ten annual installments. A Participant’s distribution election is irrevocable on December 31, 2005 or such earlier time as the Company prescribes.

 7.4 Installment Payments. Installment payments shall be calculated by dividing the Participant’s total Account by the number
of installment payments remaining. For example, if a Participant elects to receive distribution of his or her Account in ten annual installments, at the time of the first installment payment the Account is divided by ten and one-tenth of the Account

  

 9 

 
is distributed. At the time of the second installment payment the Account is divided by nine and one-ninth of the Account is distributed. At the time of the
tenth installment payment the entire Account is distributed. Pursuant to Section 7.1, the Participant’s Account will continue to be credited with earnings or losses based on the Investment Fund(s) selected by the Participant until the
final installment payment has been made. 
 7.5 Default Method of Distribution. If no distribution election is made, a Participant
shall receive distribution of amounts credited to his Account in a lump sum on the Payment Date. 
 7.6 Special Distribution Election.
The Committee may permit a Participant to make a special distribution election with respect to amounts already credited to the Participant’s account and amounts that are credited to his account following such special distribution election;
provided that such special distribution election is made prior to December 31, 2005 and otherwise in accordance with Notice 2005-1 or such other guidance as is promulgated under Code Section 409A. A Participant’s special distribution
election is irrevocable on December 31, 2005 or such earlier time as the Company prescribes. 
 7.7 Acceleration of
Distributions. Notwithstanding any other provision of the Plan to the contrary, the acceleration of the time or schedule of any payment under the Plan shall not be permitted except as permitted under Code Section 409A. 
 Section 8. Beneficiary. 
 8.1 Designation of
Beneficiary. Each Participant may designate, by filing a form provided by the Plan Committee, a Beneficiary or Beneficiaries to receive any payment in the event of the Participant’s death. A Participant who has filed a designation of
Beneficiary may revoke or change it at any time by filing a new form with the Plan Committee. 
 8.2 Automatic Designation. Unless
otherwise designated, the Beneficiary of a married Participant will automatically be his spouse, and the Beneficiary of an unmarried Participant will be his estate. 
  

 10 

 Section 9. Participant’s Rights Held in “Rabbi” Trust. 
 The Company shall establish and maintain a “Rabbi” Trust which shall be an irrevocable trust in which the Company shall deposit deferred
compensation payable to a Participant as determined in Section 5 of this Plan. Any “Rabbi” Trust assets are subject to the claims of the Company’s creditors in the event of the Company’s Insolvency, until paid to
Participants and their Beneficiaries. The “Rabbi” Trust shall constitute an unfunded arrangement providing deferred compensation for a select group of senior management executives for purposes of Title I of ERISA. 
 Section 10. Time of Allocation. 
 This Plan
shall be administered and individual Participant Accounts shall be updated at least annually. All allocations under this Plan shall be allocated as of each Valuation Date. 
 Section 11. Vesting of Plan Benefits. 
 The Account balance of a Participant or Beneficiary
under the Plan shall be 100% vested. 
 Section 12. Miscellaneous Provisions. 
 12.1 Nonassignability. An Employee’s rights and interests under this Plan may not be assigned or transferred. In the event of a
Participant’s death, payment of his Account balance shall be made to the Beneficiaries which he has designated under this Plan pursuant to the written designation filed with the Plan Committee in accordance with Section 8.1, or in the
absence of such designation, to his estate, in accordance with Section 8.2. 
 12.2 No Enlargement of Employment Rights. Nothing
contained in the Plan shall be construed as a contract of employment between the Company and any person, nor shall the Plan be deemed to give any person the right to be retained in the employ of the Company or to limit the right of the Company to
employ or discharge any person with or without cause, or to discipline any Employee. 
 12.3 Applicable Law. Except as provided by
federal law, including Code Section 409A, all questions pertaining to the validity, construction and administration of the Plan shall be determined under the laws of California. 
 12.4 Gender and Number. Except as otherwise required by the context, any masculine terminology in this document shall include the feminine, and
any singular terminology shall include the plural. 
  

 11 

 Section 13. Amendments and Termination. 
 13.1 Generally. The Board of Directors may at any time amend or terminate this Plan in whole or in part without the consent of the Participant or
his Beneficiary. No amendment however, shall divest any Participant or Beneficiary of the credits to his Account, or of any rights to which he would have been entitled if the Plan had been terminated immediately prior to the effective date of the
amendment. 
 13.2 Distribution upon Termination. Upon termination of the Plan, distributions of the credits to a Participant’s
Account shall be made in the manner and at the time heretofore prescribed; provided that no additional credits shall be made to the Account of a Participant following termination of the Plan other than investment income (and losses) credited
pursuant to Section 6. 
 Section 14. Expenses. 
 Costs of administration of the Plan will be paid by the Company as may be determined by the Board, with the exception of investment direction expenses charged to Participants in accordance with Section 6.1(a).

 Section 15. Claims Procedures. 
 15.1 Applications for Benefits and Inquiries. Any application for benefits, inquiries about the Plan or inquiries about present or future rights under the Plan must be submitted to the Plan Administrator in writing by an applicant
(or his or her authorized representative). The Plan Administrator is: 
 Dolby Laboratories, Inc. 
 100 Potrero Avenue 
 San Francisco, CA
94103-4813 
 15.2 Denial of Claims. In the event that any application for benefits is denied in whole or in part, the Plan
Administrator must provide the applicant with written or electronic notice of the denial of the application, and of the applicant’s right to review the denial. Any electronic notice will comply with the regulations of the U.S. Department of
Labor. The notice of denial will be set forth in a manner designed to be understood by the applicant and will include the following: 
  

	 	(a)	the specific reason or reasons for the denial; 

  

 12 

	 	(b)	references to the specific Plan provisions upon which the denial is based; 

  

	 	(c)	a description of any additional information or material that the Plan Administrator needs to complete the review and an explanation of why such information or material is necessary;
and 

  

	 	(d)	an explanation of the Plan’s review procedures and the time limits applicable to such procedures, including a statement of the applicant’s right to bring a civil action
under Section 502(a) of ERISA following a denial on review of the claim, as described in Section 15.4 below. 

 This
notice of denial will be given to the applicant within ninety (90) days after the Plan Administrator receives the application, unless special circumstances require an extension of time, in which case, the Plan Administrator has up to an
additional ninety (90) days for processing the application. If an extension of time for processing is required, written notice of the extension will be furnished to the applicant before the end of the initial ninety (90) day period.

 This notice of extension will describe the special circumstances necessitating the additional time and the date by which the Plan
Administrator is to render its decision on the application. 
 15.3 Request for a Review. Any person (or that person’s authorized
representative) for whom an application for benefits is denied, in whole or in part, may appeal the denial by submitting a request for a review to the Plan Administrator within sixty (60) days after the application is denied. A request for a
review shall be in writing and shall be addressed to: 
 Dolby Laboratories, Inc. 
 100 Potrero Avenue 
 San Francisco, CA 94103-4813 
 A request for review must set forth all of the grounds on which it is based, all facts in support of the request and any other matters that the applicant
feels are pertinent. The applicant (or his or her representative) shall have the opportunity to submit (or the Plan Administrator may 

  

 13 

 
require the applicant to submit) written comments, documents, records, and other information relating to his or her claim. The applicant (or his or her
representative) shall be provided, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to his or her claim. The review shall take into account all comments, documents, records
and other information submitted by the applicant (or his or her representative) relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination. 
 15.4 Decision on Review. The Plan Administrator will act on each request for review within sixty (60) days after receipt of the request,
unless special circumstances require an extension of time (not to exceed an additional sixty (60) days), for processing the request for a review. If an extension for review is required, written notice of the extension will be furnished to the
applicant within the initial sixty (60) day period. This notice of extension will describe the special circumstances necessitating the additional time and the date by which the Plan Administrator is to render its decision on the review. The
Plan Administrator will give prompt, written or electronic notice of its decision to the applicant. Any electronic notice will comply with the regulations of the U.S. Department of Labor. In the event that the Plan Administrator confirms the denial
of the application for benefits in whole or in part, the notice will set forth, in a manner calculated to be understood by the applicant, the following: 
  

	 	(a)	the specific reason or reasons for the denial; 

  

	 	(b)	references to the specific Plan provisions upon which the denial is based; 

  

	 	(c)	a statement that the applicant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to
his or her claim; and 

  

	 	(d)	a statement of the applicant’s right to bring a civil action under Section 502(a) of ERISA. 

 15.5 Rules and Procedures. The Plan Administrator will establish rules and procedures, consistent with the Plan and with ERISA, as necessary and
appropriate in carrying out its responsibilities in reviewing benefit claims. The Plan Administrator may require an applicant who wishes to submit additional information in connection with an appeal from the denial of benefits to do so at the
applicant’s own expense. 
  

 14 

 15.6 Exhaustion of Remedies. No legal action for benefits under the Plan may be brought until the
claimant (i) has submitted a written application for benefits in accordance with the procedures described by Section 15.1 above, (ii) has been notified by the Plan Administrator that the application is denied, (iii) has filed a
written request for a review of the application in accordance with the appeal procedure described in Section 15.3 above, and (iv) has been notified that the Plan Administrator has denied the appeal. Notwithstanding the foregoing, if the
Plan Administrator does not respond to a Participant’s claim or appeal within the relevant time limits specified in this Section 15, the Participant may bring legal action for benefits under the Plan pursuant to Section 502(a) of
ERISA. 
 Section 16. Execution. 
 To record the amendment and restatement of this Plan, the Company has caused its appropriate officers to affix its corporate name and seal hereto this          day of
                    , 2007. 
  

			
	
	 
		
	By	 	 
		 	President
		
	By	 	 
		 	Secretary

  

 15Exhibit 4.1

 Exhibit 4.1 
 PRICING INSTRUMENT 
 WHEREAS, the parties named herein desire to enter into certain Program Documents
(as defined herein) contained herein, each such document (unless otherwise specified in such document) dated as of January 28, 2008, relating to the issuance by Genworth Global Funding Trust 2008-4 (the “Trust”) of Notes to investors
under the secured notes program sponsored by Genworth Life and Annuity Insurance Company (“GLAIC”), the terms of such Notes as specified in the pricing supplement attached to this Pricing Instrument as Exhibit C (the “Pricing
Supplement”); 
 WHEREAS, the Trust is a trust and will be organized under and its activities will be governed by the provisions of the
Trust Agreement (set forth in Section A of this Pricing Instrument), dated as of January 28, 2008, by and between the parties thereto indicated in Section E herein; 
 WHEREAS, certain expense and indemnification arrangements between GLAIC and the Trustee, on behalf of itself and on behalf of the Trust, are governed pursuant to the provisions of the Expense and Indemnity Agreement
dated as of October 1, 2006 by and between GLAIC and the Trustee; 
 WHEREAS, certain licensing arrangements between the Trust and
Genworth Financial, Inc. will be governed pursuant to the provisions of the License Agreement dated as of October 28, 2005, by and between the Trust and Genworth Financial, Inc.; 
 WHEREAS, certain custodial arrangements for the Funding Agreement will be governed pursuant to the provisions of the Custodial Agreement (the
“Custodial Agreement”) dated as of December 7, 2005 by and among SunTrust Bank, acting as custodian (the “Custodian”), the Indenture Trustee and the Trust; 
 WHEREAS, the Notes will be issued pursuant to the Indenture (set forth in Section B of this Pricing Instrument), dated as of the Original Issue Date, by
and between the parties thereto indicated in Section E herein; 
 WHEREAS, the sale of the Notes will be governed by the Terms Agreement (set
forth in Section C of this Pricing Instrument), dated as of January 28, 2008, by and among the parties thereto indicated in Section E herein; and 
 WHEREAS, certain agreements relating to the Notes and the Funding Agreement are set forth in the Coordination Agreement (set forth in Section D of this Pricing Instrument), dated as of January 28, 2008, by and
among the parties thereto indicated in Section E herein. 
 All capitalized terms used herein and not otherwise defined will have the
meanings set forth in the Indenture. 
  

 1 

 SECTION A 
 TRUST AGREEMENT 
 This TRUST AGREEMENT (this “Trust Agreement”), dated as of January 28,
2008, is entered into by and between GSS Holdings II, Inc., a Delaware corporation, as trust beneficial owner (the “Trust Beneficial Owner”), and U.S. Bank National Association, a national banking association, as Trustee (the
“Trustee”). 
 References in the Standard Trust Terms to JPMorgan Chase Bank, N.A. shall refer to The Bank of New York
Trust Company, N.A. and its permitted successors and assigns. 
 W I T N E S S E T H: 
 WHEREAS, the Trust Beneficial Owner and the Trustee desire to authorize the issuance of a Trust Beneficial Interest and a series of Notes in connection
with the entry into this Trust Agreement; 
 WHEREAS, all things necessary to make this Trust Agreement a valid and legally binding agreement
of the Trustee and the Trust Beneficial Owner, enforceable in accordance with its terms, have been done; 
 WHEREAS, the parties intend to
provide for, among other things, (i) the issuance and sale of the Notes (pursuant to the Indenture, the Distribution Agreement and the related Terms Agreement) and the Trust Beneficial Interest, (ii) the use of the proceeds of the sale of
the Notes and Trust Beneficial Interest to acquire the Funding Agreement, and (iii) all other actions deemed necessary or desirable in connection with the transactions contemplated by this Trust Agreement; and 
 WHEREAS, the parties hereto desire to incorporate by reference those certain Standard Trust Terms, dated as of December 8, 2005, and attached to the
Pricing Instrument as Exhibit A (the “Standard Trust Terms”). 
 NOW, THEREFORE, in consideration of the agreements and
obligations set forth herein and for other good and valuable consideration, the sufficiency of which are hereby acknowledged, each party hereby agrees as follows: 
 ARTICLE 1 
 Section 1.01 Incorporation by Reference. All terms, provisions and agreements set forth
in the Standard Trust Terms (except to the extent expressly modified herein) are hereby incorporated herein by reference with the same force and effect as though fully set forth herein. All capitalized terms not otherwise defined herein (including
the recitals hereof) shall have the meanings set forth in the Standard Trust Terms (the Standard Trust Terms and this Trust Agreement, collectively, the “Trust Agreement”). To the extent that the terms set forth in Article 2 of this Trust
Agreement are inconsistent with the terms of the Standard Trust Terms, the terms set forth in Article 2 herein shall apply. 
  

 A-1 

 ARTICLE 2 
 Section 2.01 Name. The Trust created and governed by this Trust Agreement shall be the trust specified in the Pricing Instrument. The name of the Trust shall be the name specified in the first paragraph of the
Pricing Instrument, as such name may be modified from time to time by the Trustee following written notice to the Trust Beneficial Owner. 
 Section 2.02 Jurisdiction. The Trust is hereby organized in, and formed under and pursuant to, the laws of the jurisdiction specified in the Pricing Supplement. 
 Section 2.03 Initial Capital Contribution and Ownership. The Trust Beneficial Owner has paid or has caused to be paid to, or to an account at the
direction of, the Trustee, on the date hereof, the sum of $15 (or, in the case of Notes issued with original issue discount, such amount multiplied by the issue price of the Notes as specified in the Pricing Supplement). The Trustee hereby
acknowledges receipt in trust from the Trust Beneficial Owner, as of the date hereof, of the foregoing contribution, which shall be used along with the proceeds from the sale of the series of Notes to purchase the Funding Agreement. Upon the
creation of the Trust and the registration of the Trust Beneficial Interest in the Securities Register (as defined in the Trust Agreement) by the Trust Registrar in the name of the Trust Beneficial Owner, the Trust Beneficial Owner shall be the sole
beneficial owner of the Trust. 
 Section 2.04 Acknowledgment. The Trustee, on behalf of the Trust, expressly acknowledges its duties
and obligations set forth in the Standard Trust Terms incorporated herein by reference. 
 Section 2.05 Additional Terms.
Section 5.01(a) of the Standard Trust Terms is hereby replaced with the following: “it is a national banking association duly organized, validly existing and in good standing under the laws of the United States of America and it is a
“bank” within the meaning of Section 581 of the Code;”. 
 Section 2.06 Pricing Instrument; Execution and
Incorporation of Terms. 
 The parties hereto will enter into the Trust Agreement by executing the Pricing Instrument. 
 By executing the Pricing Instrument, the Trustee and the Trust Beneficial Owner hereby agree that the Trust Agreement will constitute a legal, valid and
binding agreement between the Trustee and the Trust Beneficial Owner. 
 All terms relating to the Trust or the series of Notes not otherwise
included herein will be as specified in the Pricing Instrument or Pricing Supplement, as indicated herein. 
 Section 2.07 Governing
Law. This Trust Agreement will be governed by, and construed in accordance with, the laws of the jurisdiction specified in the Pricing Supplement. 
  

 A-2 

 Section 2.08 Counterparts. The Trust Agreement, through the Pricing Instrument, may be executed in
any number of counterparts, each of which counterparts shall be deemed to be an original, and all of which counterparts shall constitute but one and the same instrument. 
  

 A-3 

 SECTION B 
 INDENTURE 
 This INDENTURE (this “Indenture”) is entered into as of the Original Issue Date by and
between the Genworth Global Funding Trust specified in the Pricing Instrument (the “Trust”) and The Bank of New York Trust Company, N.A., as the indenture trustee (the “Indenture Trustee”). 
 The Bank of New York Trust Company, N.A., in its capacity as Indenture Trustee, hereby accepts its role as Registrar, Paying Agent, Transfer Agent and
Calculation Agent hereunder. 
 References herein to “Indenture Trustee,” “Registrar,” “Transfer Agent,”
“Paying Agent” or “Calculation Agent” shall include the permitted successors and assigns of any such entity from time to time and references in the Standard Indenture Terms to The Bank of New York shall refer to U.S. Bank
National Association and its permitted successors and assigns. 
 W I T N E S S E T H: 
 WHEREAS, the Trust has duly authorized the execution and delivery of this Indenture to provide for the issuance of Notes; 
 WHEREAS, all things necessary to make this Indenture a valid and legally binding agreement of the Trust and the other parties to this Indenture,
enforceable in accordance with its terms, have been done, and the Trust proposes to do all things necessary to make the Notes, when executed by the Trust and authenticated and delivered pursuant hereto, valid and legally binding obligations of the
Trust as hereinafter provided; and 
 WHEREAS, the parties hereto desire to incorporate by reference those certain Standard Indenture Terms,
dated as of December 8, 2005, and attached to the Pricing Instrument as Exhibit B (the “Standard Indenture Terms”). 
 NOW, THEREFORE, for and in consideration of the premises and the purchase of the Notes by the Holders thereof, it is mutually covenanted and agreed by each of the parties hereto as follows: 
 ARTICLE 1 
 Section 1.01 Incorporation by
Reference. All terms, provisions and agreements set forth in the Standard Indenture Terms (except to the extent expressly modified herein) are hereby incorporated herein by reference with the same force and effect as though fully set forth
herein. All capitalized terms not otherwise defined herein (including the recitals hereof) shall have the meanings set forth in the Standard Indenture Terms (the Standard Indenture Terms and this Indenture, collectively, the “Indenture”).
To the extent that the terms set forth in Article 2 of this Indenture are inconsistent with the terms of the Standard Indenture Terms, the terms set forth in Article 2 herein shall apply. 
  

 B-1 

 ARTICLE 2 
 Section 2.01 Agreement to be Bound. Each of the Trust, the Indenture Trustee, the Registrar, the Transfer Agent, the Paying Agent and the Calculation Agent hereby agrees to be bound by all of the terms,
provisions and agreements set forth in the Indenture, with respect to all matters contemplated in the Indenture, including, without limitation, those relating to the issuance of the below-referenced Notes. 
 Section 2.02 Designation of the Trust, the Notes and the Funding Agreement. The Trust created by the Trust Agreement specified in the Pricing
Instrument and referred to herein is the Genworth Global Funding Trust specified in the Pricing Instrument. The Notes issued by the Trust and governed by the Indenture shall be the Notes specified in the Pricing Supplement. The Funding Agreement
designated hereby is the Funding Agreement designated in the Pricing Supplement, effective as of the Original Issue Date, between the Trust and Genworth Life and Annuity Insurance Company. 
 Section 2.03 Additional Terms. Notwithstanding anything to the contrary in Section 2.04(c) of the Standard Indenture Terms, the Indenture
Trustee will give written notice of redemption to the Holders in accordance with Section 1.06 of the Standard Indenture Terms not more than seventy-five (75) calendar days and not less than thirty (30) calendar days prior to the date
set for such redemption. Notwithstanding anything to the contrary in Section 2.04(f) of the Standard Indenture Terms, the Indenture Trustee shall treat as satisfactory to it thirty-five (35) calendar days’ notice from the Trust (or
from GLAIC on behalf of the Trust) of a redemption date for the Notes; provided that there are at least three Business Days between the receipt by it of such notice and the deadline for giving notice of such redemption under Section 2.04(c);
provided further that the Notes are in the form of Global Notes and the redemption is in whole. The initial principal amount of the Notes shall be $33,512,000.00. 
 Section 2.04 Pricing Instrument; Execution and Incorporation of Terms. 
 The parties hereto will
enter into this Indenture by executing the Pricing Instrument. 
 By executing the Pricing Instrument, the Indenture Trustee, the Registrar,
the Transfer Agent, the Paying Agent, the Calculation Agent and the Trust hereby agree that the Indenture will constitute a legal, valid and binding agreement between the Indenture Trustee, the Registrar, the Transfer Agent, the Paying Agent, the
Calculation Agent and the Trust. 
 All terms relating to the Trust or the Notes not otherwise included herein will be as specified in the
Pricing Instrument or Pricing Supplement, as indicated herein. 
 Section 2.05 Counterparts. This Indenture, through the Pricing
Instrument, may be executed in any number of counterparts, each of which counterparts shall be deemed to be an original, and all of which counterparts shall constitute one and the same instrument. 
 [Remainder of Page Left Intentionally Blank] 
  

 B-2 

 SECTION C 
 TERMS AGREEMENT 
 This TERMS AGREEMENT (this “Terms Agreement”) is entered into as of
January 28, 2008 by and among Genworth Life and Annuity Insurance Company (“GLAIC”), the Genworth Global Funding Trust specified in the Pricing Instrument (the “Trust”) and the Agent specified in the Pricing Supplement (the
“Agent”). 
 W I T N E S S E T H: 
 WHEREAS, GLAIC and the Agent have entered into that certain Distribution Agreement dated December 9, 2005 (the “Distribution Agreement”). 
 NOW, THEREFORE, in consideration of the mutual promises set forth herein and other good and valuable consideration, the sufficiency and receipt of which
are hereby acknowledged, each of the parties hereby agrees as follows: 
 ARTICLE 1 
 Section 1.01 Incorporation by Reference. The provisions of the Distribution Agreement and the related definitions (unless otherwise specified
herein) are incorporated by reference herein and shall be deemed to have the same force and effect as if set forth in full herein. 
 ARTICLE
2 
 Section 2.01 Addition of Trust as Party to Distribution Agreement. 
 Pursuant to Section 1 of the Distribution Agreement, each of the undersigned parties hereby acknowledges and agrees that the Trust, upon execution
hereof by the Trust and the other parties to this Terms Agreement, shall become a Trust for purposes of the Distribution Agreement in accordance with the terms thereof, in respect of the Notes, with all the authority, rights, powers, duties and
obligations of a Trust under the Distribution Agreement. The Trust confirms that any agreement, covenant, acknowledgment, representation or warranty under the Distribution Agreement applicable to the Trust is made by the Trust at the date hereof,
unless another time or times are specified in the Distribution Agreement, in which case such agreement, covenant, acknowledgment, representation or warranty shall be deemed to be confirmed by the Trust at such specified time or times. 
 All references to Section 9 (Indemnification) of the Distribution Agreement to “solely with respect to the applicable Agent(s) or
Co-Agent(s)” will include all of such Agent’s or Co-Agent’s directors and officers and each person, if any, who controls such Agent or Co-Agent within the meaning of Section 15 of the Securities Act of 1933, as amended or
Section 20 of the Securities Exchange Act of 1934, as amended. All references in the Distribution Agreement to the “Registration Statement”, the “Institutional Base Prospectus”, the “Retail Base Prospectus”, any
“preliminary prospectus”, the “Time of Sale Prospectus” and the “Prospectus” shall also be deemed to include all documents incorporated by reference therein. 
  

 C-1 

 Section 2.02 Purchase of Notes as Principal. 
 (a) Subject in all respects to the terms and conditions of the Distribution Agreement, the Trust hereby agrees to sell to the Agent and the Agent hereby
agrees to purchase the Notes having the terms specified in the Pricing Supplement relating to such Notes. The initial principal amount of the Notes is $33,512,000.00. 
 (b) In connection with any purchase of Notes from the Trust by the Agent as principal, the parties agree that the items specified on Schedule I of the Pricing Instrument will be delivered as of the Settlement Date.

 Section 2.03 Termination. Upon the termination of this Terms Agreement pursuant to Section 13(b) of the Distribution
Agreement the undersigned parties hereby agree to allocate the expenses reasonably incurred prior to or in connection with such termination as follows: 
 The expenses will be borne by GLAIC. 
 Section 2.04 Applicable Time. For purposes of the
Distribution Agreement, the Applicable Time shall be 3:26 pm EST, January 28, 2008. 
 Section 2.05 Governing Law. This
Terms Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to the principles of conflicts of laws thereof. 
 Section 2.06 Notices. For purposes of Section 14 of the Distribution Agreement, the Trust’s communications details are as set forth in Section D of the Pricing Instrument. 
 Section 2.07 Additional Terms. The Agent represents, warrants and covenants with or to (as the case may be) the Trust and the Company that it
has not offered, sold or delivered and it will not offer, sell or deliver, any of the Notes, in or from any jurisdiction except under circumstances that are reasonably designed to result in compliance with the applicable securities laws and
regulations thereof. 
 Section 2.08 Pricing Instrument; Execution and Incorporation of Terms. 
 The parties hereto will enter into this Terms Agreement by executing the Pricing Instrument. 
 By executing the Pricing Instrument, each party hereto agrees that this Terms Agreement will constitute a legal, valid and binding agreement by and among
such parties. 
 All terms relating to the Trust or the Notes not otherwise included in this Terms Agreement will be as specified in the
Pricing Instrument or Pricing Supplement, as indicated herein. 
 Section 2.09 Counterparts. This Terms Agreement, through the
Pricing Instrument, may be executed in any number of counterparts, each of which counterparts shall be deemed to be an original, and all of which counterparts shall constitute but one and the same instrument. 
  

 C-2 

 SECTION D 
 COORDINATION AGREEMENT 
 This COORDINATION AGREEMENT (this “Coordination Agreement”), dated as of
January 28, 2008, is entered into by and among Genworth Life and Annuity Insurance Company (“GLAIC”), the Genworth Global Funding Trust specified in the Pricing Instrument (the “Trust”), SunTrust Bank, in its capacity as
custodian of the Funding Agreement (“Custodian”) and The Bank of New York Trust Company, N.A., as the indenture trustee (the “Indenture Trustee”). 
 W I T N E S S E T H 
 WHEREAS, the Trust will enter into the Funding Agreement with GLAIC, effective as of
the Original Issue Date specified in the Pricing Supplement; 
 WHEREAS, the Agents (as defined in the Distribution Agreement) will sell the
Notes in accordance with the Registration Statement; 
 WHEREAS, the Trust intends to issue the Notes in accordance with the Indenture, to
collaterally assign to, and grant a security interest in, the Funding Agreement to and in favor of the Indenture Trustee in accordance with the Indenture to secure payment of the Notes; and 
 WHEREAS, the Custodian will hold the Funding Agreement on behalf of the Indenture Trustee pursuant to the terms of the Custodial Agreement. 

NOW, THEREFORE, to give effect to the agreements and arrangements established under the Terms Agreement included in the Pricing Instrument, as
applicable, the Trust Agreement, the Indenture and the Notes, and in consideration of the agreements and obligations set forth herein and for other good and valuable consideration, the sufficiency of which are hereby acknowledged, each party hereby
agrees as follows: 
 ARTICLE 1 
 Section 1.01 Delivery of the Funding Agreement. The Trust hereby authorizes the Custodian, on behalf of the Indenture Trustee, to receive the Funding Agreement from GLAIC pursuant to the assignment of the Funding Agreement (the
“Assignment”), to be entered into on the Original Issue Date, included in the closing instrument dated as of the Original Issue Date (the “Closing Instrument”). 
 Section 1.02 Issuance and Purchase of the Notes. 
 (a) Delivery of the Funding Agreement to the Custodian, on behalf of the Indenture Trustee, pursuant to the Assignment or execution of the cross-receipt contained in the Closing Instrument shall be confirmation of
payment by the Trust for the Funding Agreement. 
  

 D-1 

 (b) The Trust hereby directs the Indenture Trustee, upon receipt of the Funding Agreement by the
Custodian, on behalf of the Indenture Trustee and pursuant to the Assignment, (i) to authenticate the certificates representing the Notes (the “Certificates”) in accordance with the Indenture and (ii) to (A) deliver each
relevant Certificate to the clearing system or systems identified in each such Certificate, or to the nominee of such clearing system, or the custodian thereof, for credit to such accounts as the Agent may direct, or (B) deliver each relevant
Certificate to the purchasers thereof as identified by the Agent. 
 ARTICLE 2 
 Section 2.01 Directions Regarding Periodic Payments. As registered owner of the Funding Agreement as collateral securing payments on the Notes,
the Indenture Trustee will receive payments on the Funding Agreement on behalf of the Trust. The Trust hereby directs the Indenture Trustee to use such funds to make payments on behalf of the Trust pursuant to the Trust Agreement and the Indenture.

 Section 2.02 Maturity of the Funding Agreement. Upon the maturity of the Funding Agreement and the return of funds thereunder, the
Trust hereby directs the Indenture Trustee to set aside from such funds an amount sufficient for the repayment of the outstanding principal on the Notes and Trust Beneficial Interest when due. 
 ARTICLE 3 
 Section 3.01 Officer’s Certificates. GLAIC hereby agrees to
deliver an Officer’s Certificate, a copy of which is attached hereto as Exhibit D, on a quarterly basis to any rating agency currently rating the Program. The Trust hereby agrees to deliver an Officer’s Certificate, a copy of which is
attached to the Pricing Instrument as Exhibit E, on a quarterly basis to any rating agency currently rating the Program. 
 Section 3.02
Filings. GLAIC hereby covenants to file, or cause to be filed, in a timely manner on behalf of the Trust all reports, certifications or similar filings required under the Securities Exchange Act of 1934, as amended. 
 ARTICLE 4 
 Section 4.01 No Additional
Liability. Nothing in this Coordination Agreement shall impose any liability or obligation on the part of any party to this Coordination Agreement to make any payment or disbursement in addition to any liability or obligation such party has
under the Program Documents, except to the extent that a party has actually received funds which it is obligated to disburse pursuant to this Coordination Agreement. 
 Section 4.02 No Conflict. This Coordination Agreement is intended to be in furtherance of the agreements reflected in the documents related to the Program Documents, and not in conflict. To the extent that a
provision of this Coordination Agreement conflicts with the provisions of one or more Program Documents, the provisions of such Program Documents shall govern. 
 Section 4.03 Governing Law. This Coordination Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to the principles of conflicts of laws thereof.

  

 D-2 

 Section 4.04 Severability. If any provision in this Coordination Agreement shall be invalid,
illegal or unenforceable, such provision shall be deemed severable from the remaining provisions of this Coordination Agreement and shall in no way affect the validity or enforceability of such other provisions of this Coordination Agreement.

 Section 4.05 Notices. All demands, notices and communications under this Coordination Agreement shall be in writing and shall be
deemed to have been duly given upon receipt at the addresses set forth below: 
 To the Trust: 
 Genworth Global Funding Trust 2008-4 
 c/o
U.S. Bank National Association 
 Corporate Trust Services 
 209 S. LaSalle Street, Suite 300 
 Chicago, Illinois 60604 
 Attention: Patricia Child, VP 
 Facsimile:
(312) 325-8905 
 To the Indenture Trustee: 
 The Bank of New York Trust Company, N.A. 
 2 North LaSalle Street, Suite 1020 
 Chicago, Illinois 60602 
 Attention: Corporate
Finance 
 Facsimile: (312) 827-8542 
 To GLAIC: 
 Genworth Life and Annuity Insurance Company 
 6610 West Broad Street 
 Richmond, Virginia
23230 
 Attention: Treasurer 
 Facsimile: (804) 662-7777 
 with a copy to: 
 Genworth Life and Annuity Insurance Company 
 6610 West Broad Street 
 Richmond, Virginia 23230 
 Attention: Heather
Harker, Esq. 
 Facsimile: (804) 281-6005 
 To the Custodian: 
 SunTrust Bank 
 919 East Main Street 
 Richmond, Virginia
23219 
 Attention: Retirement Services 
 Facsimile: (804) 782-7439 
 or at such other address as shall be designated by any such party in a written notice to the other parties.

  

 D-3 

 ARTICLE 5 
 Section 5.01 Pricing Instrument; Execution and Incorporation of Terms. 
 The parties to this
Coordination Agreement will enter into this Coordination Agreement by executing the Pricing Instrument. 
 By executing the Pricing
Instrument, each party hereto agrees that this Coordination Agreement will constitute a legal, valid and binding agreement by and among the Trust, GLAIC, the Custodian and the Indenture Trustee. 
 All terms relating to the Trust or the Notes not otherwise included in this Coordination Agreement will be as specified in the Pricing Instrument or
Pricing Supplement, as indicated herein. 
 Section 5.02 Counterparts. This Coordination Agreement, through the Pricing Instrument,
may be executed in any number of counterparts, each of which counterparts shall be deemed to be an original, and all of which counterparts shall constitute but one and the same instrument. 
 Section 5.03 Capitalized Terms. All capitalized terms used herein and not otherwise defined in this Coordination Agreement will have the meanings
set forth in the Indenture. 
 [Remainder of Page Left Intentionally Blank] 
  

 D-4 

 SECTION E 
 MISCELLANEOUS AND EXECUTION PAGES 
 This Pricing Instrument may be executed by each of the parties hereto in
any number of counterparts, and by each of the parties hereto on separate counterparts, each of which counterparts, when so executed and delivered, shall be deemed to be an original, but all such counterparts shall together constitute but one and
the same instrument. 
 Each signatory, by its execution hereof, does hereby become a party to each of the agreements or indenture identified
for such party as of the date specified in such agreements or indenture. 
 IN WITNESS WHEREOF, the undersigned have executed this Pricing
Instrument with respect to the Notes as of the date first written above. 
  

			
	GENWORTH LIFE AND ANNUITY INSURANCE COMPANY (in executing below agrees and becomes a party to (i) the Terms Agreement set forth in Section C herein and (ii) the
Coordination Agreement set forth in Section D herein)
		
	By:	 	/s/ Pamela C. Asbury
		 	Name: Pamela C. Asbury
		 	Title: Vice President

 [Execution Page 1 of 3] 
  

 E-1 

					
	THE GENWORTH GLOBAL FUNDING TRUST DESIGNATED IN THIS PRICING INSTRUMENT (in executing below agrees and becomes a party to (i) the Indenture set forth in Section B herein,
(ii) the Terms Agreement set forth in Section C herein and (iii) the Coordination Agreement set forth in Section D herein)
	
	By: U.S. BANK NATIONAL ASSOCIATION, not in its individual capacity but solely in its capacity as Trustee of the Trust
		
	By:	 	/s/ Patricia M. Child
		 	Name:	 	Patricia M. Child
		 	Title:	 	Vice President
	
	U.S. BANK NATIONAL ASSOCIATION (in executing below agrees and becomes a party to the Trust Agreement set forth in Section A herein), as Trustee
		
	By:	 	/s/ Patricia M. Child
		 	Name:	 	Patricia M. Child
		 	Title:	 	Title:Vice President
	
	U.S. BANK NATIONAL ASSOCIATION (in executing below acknowledges and agrees to Section 5.01 of the Trust Agreement as set forth in and amended by Section A herein), in its
individual capacity
		
	By:	 	/s/ Patricia M. Child
		 	Name:	 	Patricia M. Child
		 	Title:	 	Vice President
	
	GSS HOLDINGS II, INC. (in executing below agrees and becomes a party to the Trust Agreement set forth in Section A herein), as Trust Beneficial Owner
		
	By:	 	/s/ Bernard J. Angelo
		 	Name:	 	Bernard J. Angelo
		 	Title:	 	Vice President

 [Execution Page 2 of 3] 
  

 E-2 

					
	THE BANK OF NEW YORK TRUST COMPANY, N.A. (in executing below agrees and becomes a party to (i) the Indenture set forth in Section B herein, as Indenture Trustee, Registrar,
Transfer Agent, Paying Agent and Calculation Agent and (ii) the Coordination Agreement set forth in Section D herein), as Indenture Trustee, Registrar, Transfer Agent, Paying Agent and Calculation Agent
		
	By:	 	/s/ R. Tarnas
		 	Name:	 	R. Tarnas
		 	Title:	 	Vice President
	
	SUNTRUST BANK (in executing below agrees and becomes a party to the Coordination Agreement set forth in Section D herein), as Custodian
		
	By:	 	/s/ Richard J. Owens, III
		 	Name:	 	Richard J. Owens, III
		 	Title:	 	VP/ Trust Officer
	
	LASALLE FINANCIAL SERVICES, INC. (in executing below agrees and becomes a party to the Terms Agreement set forth in Section C herein)
		
	By:	 	/s/ Stephen Burkin
		 	Name:	 	 Stephen Burkin 

		 	Title:	 	SVP

 [Execution Page 3 of 3] 
  

 E-3 

 EXHIBIT A 
 Standard Trust Terms 
 As filed as Exhibit 4.5 to the Registration Statement on Form S-3 (File No. 333-128718), filed
by Genworth Life and Annuity Insurance Company with the Securities and Exchange Commission (the “Commission”) on September 30, 2005, as amended by Amendment No. 1, filed with the Commission on December 8, 2005. 

 

 A-1 

 EXHIBIT B 
 Standard Indenture Terms 
 As filed as Exhibit 4.1 to the Registration Statement on Form S-3 (File No. 333-128718),
filed by Genworth Life and Annuity Insurance Company with the Securities and Exchange Commission (the “Commission”) on September 30, 2005, as amended by Amendment No. 1, filed with the Commission on December 8, 2005.

  

 B-1 

 EXHIBIT C 
 Pricing Supplement 
 As filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act,
dated as of January 22, 2008, with respect to the Notes to be issued by the Trust. 
  

 C-1 

 EXHIBIT D 
 Genworth Life and Annuity Insurance Company 
 Officer’s Certificate 
 The undersigned, an officer of Genworth Life and Annuity Insurance Company, a stock life insurance company operating under a charter granted by the
Commonwealth of Virginia (“GLAIC”), does hereby certify to Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies, Inc., in such capacity and on behalf of GLAIC, to the knowledge of the undersigned and
after reasonable inquiry, that: 
  

	 	1.	each of the representations and warranties of GLAIC contained in each Expense and Indemnity Agreement entered into in connection with the Registration Statement (defined below), and
each Funding Agreement issued in connection with the Program (the “Specified Agreements”) (other than any representation or warranty expressly made as of a date prior to the date hereof) are true and correct on and as of the date hereof,
with the same effect as though such representation or warranty had been made on and as of the date hereof; 

  

	 	2.	no default under any of the Specified Agreements and no event or any condition which, with notice or lapse of time or both, would become a default, has occurred and is continuing as
of the date hereof; 

  

	 	3.	GLAIC has performed and complied with, in all material respects, all of the agreements, covenants, obligations and conditions applicable to GLAIC required by the Specified
Agreements to be performed or complied with by GLAIC on or before the date hereof; 

  

	 	4.	the Registration Statement filed on Form S-3 (File No. 333-128718) (the “Registration Statement”) by GLAIC has been declared effective by the Securities and Exchange
Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”) and no stop order suspending the effectiveness of the Registration Statement has been issued and no proceedings for that purpose have been
commenced by or are pending before or contemplated by the Commission; 

  

	 	5.	all filings, if any, required by Rule 424 and Rule 430A under the Act have been made in a timely manner; 

  

	 	 6.
	 since [·]1, the Trusts organized in connection with the program contemplated
by the Registration Statement have issued the following series of Notes: 

 [List each series of Notes]
[(collectively, the “Designated Notes”)]; and 
  

	 	7.	the Funding Agreements issued in connection with the Designated Notes have been executed and delivered by GLAIC in accordance with the terms and conditions of the Program Documents.

  
  

	 1
	 This certificate to be signed quarterly. 

  

 D-1 

 Capitalized terms used herein and not otherwise defined herein shall have the meanings set forth in the
Standard Indenture Terms attached as Exhibit 4.1 to the Registration Statement. 
 IN WITNESS WHEREOF, the undersigned has executed this
Certificate as of the [·] day of [·] 200[·]. 
  

			
	[Name], in [his/her] capacity as an authorized officer of Genworth Life and Annuity Insurance Company
		
	By:	 	 
		 	Name:
		 	Title:

  

 D-2 

 EXHIBIT E 
 Genworth Global Funding Trusts Trustee 
 Officer’s Certificate 
 U.S. Bank National Association, not in its individual capacity but solely in its capacity as trustee acting on behalf of each common law trust organized
under the laws of the State of Illinois (in such capacity, the “Trustee,” and each such common law trust being referred to herein as a “Trust”) in connection with the program contemplated by the Registration Statement filed on
Form S-3 (File No. 333-128718) by Genworth Life and Annuity Insurance Company with the Securities and Exchange Commission (the “Commission”) on September 30, 2005, as amended by Amendment No. 1, filed with the Commission on
December 8, 2005 (the “Registration Statement”), does hereby certify to Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies, Inc., in such capacity and on behalf of each Trust, to the knowledge of
the Trustee without any independent investigation, that; as of October 1, 2006: 
  

	 	1.	each of the representations and warranties of each Trust contained in the Notes issued in connection with the Program, each Indenture entered into in connection with the
Registration Statement and the Expense and Indemnity Agreement concerning the Trusts (the “Specified Agreements”) (other than any representation or warranty expressly made as of a date prior to the date hereof) are true and correct on and
as of the date hereof, with the same effect as though such representation or warranty had been made on and as of the date hereof; 

  

	 	2.	no default under any of the Specified Agreements and no event or any condition which, with notice or lapse of time or both, would become a default, has occurred and is continuing as
of the date hereof; 

  

	 	3.	each Trust has performed and complied with, in all material respects, all of the agreements, covenants, obligations and conditions applicable to such Trust required by the Specified
Agreements to be performed or complied with by such Trust on or before the date hereof; 

  

	 	4.	the Notes issued in connection with the Program have been issued, in all material respects, in accordance with the terms and conditions of the Program Documents; and

  

	 	5.	each Funding Agreement has been executed and delivered by the related Trust in accordance with the terms and conditions of the Program Documents. 

 Capitalized terms used herein and not otherwise defined herein shall have the meanings set forth in the Standard Indenture Terms attached as Exhibit 4.1
to the Registration Statement. In no event shall U.S. Bank National Association in its personal corporate capacity (or any officer of the Trustee in his or her personal capacity) have any liability for any of the certifications or statements
contained in this Trustee Officer’s Certificate, such liability being solely that of each Trust. 
  

 E-1 

 IN WITNESS WHEREOF, the undersigned has executed this Certificate as of the [·
] day of [·], 200[·]. 
  

			
	U.S. Bank National Association, not in its individual capacity but solely in its capacity as Trustee acting on behalf of each Trust
		
	By:	 	 
		 	Name:
		 	Title:

  

 E-2 

 SCHEDULE I 
 Terms Agreement Specifications 
 In connection with Section 3(a)(iv) of the Distribution Agreement, the Program under
which the Notes are issued is rated Aa3 by Moody’s Investors Service, Inc. (“Moody’s”) and AA- by Standard & Poor’s Rating Services, a division of The McGraw-Hill Companies, Inc. (“S&P”). Genworth Life
and Annuity Insurance Company (“GLAIC”) expects that the Notes will be rated Aa3 by Moody’s and AA- by S&P. GLAIC’s financial strength rating is Aa3 by Moody’s and AA- by S&P. 
 In accordance with Section 2.02(b) of the Terms Agreement and in connection with the purchase of Notes from the Trust by the Agent, the following items will be
delivered on or prior to the Settlement Date to the Agent: None. 
 All capitalized terms used herein and not otherwise defined herein will
have the meanings set forth in the Distribution Agreement. 
  

 I-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00135-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00135-of-00352.parquet"}]]